Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
Cara Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Cara Therapeutics reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, four executives at Cara Therapeutics received on average a compensation package of $2.1M, a 12% decrease compared to previous year.
Average pay of disclosed executives at Cara Therapeutics
Derek Chalmers, Chief Executive Officer, received $3.4M in total, which increased by 23% compared to 2018. 74% of Chalmers' compensation, or $2.6M, was in option awards. Chalmers also received $311K in non-equity incentive plan, $560K in salary, as well as $11K in other compensation.
Frédérique Menzaghi, Chief Scientific Officer, received a compensation package of $2.2M, which increased by 80% compared to previous year. 73% of the compensation package, or $1.6M, was in option awards.
Scott Terrillion, General Counsel, earned $1.4M in 2019.
Mani Mohindru, Chief Financial Officer, received $1.3M in 2019.
Related executives
You may also like
Source: SEC filing on April 22, 2020.